Rufloxacin Hydrochloride is a fluoroquinolone antibiotic used in the treatment of bacterial infections, including urinary tract infections, by inhibiting DNA gyrase and topoisomerase IV enzymes. To support… Read more
Rufloxacin Hydrochloride is a fluoroquinolone antibiotic used in the treatment of bacterial infections, including urinary tract infections, by inhibiting DNA gyrase and topoisomerase IV enzymes. To support stringent pharmaceutical analysis, this category provides essential reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for accurate impurity profiling, method validation, and routine quality control assessments. By providing traceable reference materials for metabolic studies and analytical method development, these compounds ensure compliance with regulatory standards throughout the drug development lifecycle. These specialized reagents are critical for isolating and quantifying degradation products and synthesis by-products, ensuring the safety and efficacy of the medication during manufacturing and shelf-life monitoring.